About Evotec Neurosciences
Evotec Neurosciences discovers and develops therapeutics for the treatment of Alzheimer's disease and other Central Nervous System (CNS) disorders with high unmet medical needs.On March 14, 2005, Evotec Neurosciences was acquired by Evotec.52M.
Missing: Evotec Neurosciences's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Evotec Neurosciences's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Evotec Neurosciences Frequently Asked Questions (FAQ)
Where is Evotec Neurosciences's headquarters?
Evotec Neurosciences's headquarters is located at Schnackenburgallee 114, Hamburg.
What is Evotec Neurosciences's latest funding round?
Evotec Neurosciences's latest funding round is Acquired.
How much did Evotec Neurosciences raise?
Evotec Neurosciences raised a total of $30.65M.
Who are the investors of Evotec Neurosciences?
Investors of Evotec Neurosciences include Evotec SE, 3i Group and TVM Capital Life Science.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.